Doceree at Solli Summit 2026: A Post-Event Reflection from the Forefront of Pharma Media
The Solli Summit 2026 arrived at a defining moment for pharma media. Across the industry, healthcare marketing trends are shifting faster than traditional campaign cycles can accommodate - driven by the accelerating role of AI in healthcare marketing, growing demands for measurable outcomes, and a fundamental rethink of HCP engagement strategy. Doceree was proud to be part of that conversation, contributing thought leadership that sits at the intersection of technology, data, and pharma marketing innovation - and engaging with the partners shaping what comes next.
Intent-Based Marketing in Pharma: The Clock Is Always Running
Harshit Jain, MD, Founder & Global CEO, Doceree, brought one of the summit's most compelling arguments to the stage: physician intent has a half-life. A prescribing cue - a patient presenting with a condition, a diagnosis confirmed, a treatment decision forming - opens a narrow, high-value engagement window. Miss it, and the signal is gone.
Most pharma campaigns, however, are optimised on planning cycles that lag weeks or months behind that moment. Harshit's session made an urgent case for why intent-based marketing in pharma must be rebuilt around real-time clinical signals and precise healthcare professional targeting. In the future of pharma advertising, timing and precision are inseparable - and the brands investing in that infrastructure today will define the category tomorrow.
AI in Healthcare Marketing and the Transparency Imperative
Kamya Elawadhi, Co-Founder & President, Doceree, moderated "From Black Boxes to Glass Boxes - The Future of Media Transparency in Healthcare," one of Solli Summit 2026's most talked-about panels. Her message was direct - the era of impressions as proof of performance is over. She was joined on the panel by Jeff McDonald, CEO & Co-Founder, Kythera Labs; Brad Liebow, Chief Investment Officer, Publicis Health Media; and Jill Kregel, Head of Partnerships, Health Omnicom - each bringing a distinct industry lens to the conversation around accountability, measurement, and the future of pharma media transparency.
Data-driven pharma marketing now requires verified, attributable outcomes. Moving beyond clicks in pharma marketing is no longer a best practice; it is fast becoming the standard. Running alongside this was a broader summit-wide conversation about how AI is transforming healthcare marketing - from predictive audience segmentation to agentic AI workflows that can orchestrate personalised HCP engagement at scale. Digital transformation in pharma has moved decisively from aspiration to operational reality.
The Future of Pharma Media Is Already Here
Doceree left the Solli Summit 2026 with sharper thinking and stronger conviction. The pharma media trends 2026 has surfaced are not on the horizon - they are live, in briefs, budgets, and boardrooms right now. AI in healthcare marketing, real-time intent infrastructure, and transparent programmatic environments are the present standard, not the next frontier.
At Doceree, we remain committed to building the platforms and partnerships that make smarter, more meaningful HCP engagement possible at scale - for brands, for publishers, and for the healthcare professionals at the centre of every decision. The signal is live. The moment is now.
Know more about our upcoming events: Doceree events